JP2022532657A - エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 - Google Patents

エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 Download PDF

Info

Publication number
JP2022532657A
JP2022532657A JP2021568373A JP2021568373A JP2022532657A JP 2022532657 A JP2022532657 A JP 2022532657A JP 2021568373 A JP2021568373 A JP 2021568373A JP 2021568373 A JP2021568373 A JP 2021568373A JP 2022532657 A JP2022532657 A JP 2022532657A
Authority
JP
Japan
Prior art keywords
months
ephedrine
less
composition
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568373A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020232424A5 (https=
JP2022532657A5 (https=
Inventor
シャヒード アハメド，
Original Assignee
ネクサス ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73230956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2022532657(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ネクサス ファーマシューティカルズ， インコーポレイテッド filed Critical ネクサス ファーマシューティカルズ， インコーポレイテッド
Publication of JP2022532657A publication Critical patent/JP2022532657A/ja
Priority to JP2023079995A priority Critical patent/JP2023091072A/ja
Publication of JPWO2020232424A5 publication Critical patent/JPWO2020232424A5/ja
Publication of JP2022532657A5 publication Critical patent/JP2022532657A5/ja
Priority to JP2025026685A priority patent/JP2025071269A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021568373A 2019-05-16 2020-05-16 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 Pending JP2022532657A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023079995A JP2023091072A (ja) 2019-05-16 2023-05-15 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
JP2025026685A JP2025071269A (ja) 2019-05-16 2025-02-21 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962849125P 2019-05-16 2019-05-16
US62/849,125 2019-05-16
PCT/US2020/033310 WO2020232424A1 (en) 2019-05-16 2020-05-16 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023079995A Division JP2023091072A (ja) 2019-05-16 2023-05-15 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法

Publications (3)

Publication Number Publication Date
JP2022532657A true JP2022532657A (ja) 2022-07-15
JPWO2020232424A5 JPWO2020232424A5 (https=) 2023-05-23
JP2022532657A5 JP2022532657A5 (https=) 2023-05-23

Family

ID=73230956

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021568373A Pending JP2022532657A (ja) 2019-05-16 2020-05-16 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
JP2023079995A Withdrawn JP2023091072A (ja) 2019-05-16 2023-05-15 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
JP2025026685A Pending JP2025071269A (ja) 2019-05-16 2025-02-21 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023079995A Withdrawn JP2023091072A (ja) 2019-05-16 2023-05-15 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
JP2025026685A Pending JP2025071269A (ja) 2019-05-16 2025-02-21 エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法

Country Status (10)

Country Link
US (7) US11090278B2 (https=)
EP (1) EP3968975A4 (https=)
JP (3) JP2022532657A (https=)
KR (2) KR20240096847A (https=)
CN (1) CN113825500A (https=)
AU (1) AU2020276619A1 (https=)
CA (1) CA3140043A1 (https=)
IL (1) IL288044A (https=)
MX (1) MX2021013888A (https=)
WO (1) WO2020232424A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods
US20230172840A1 (en) * 2021-12-05 2023-06-08 Fresenius Kabi Austria Gmbh Ephedrine liquid formulations
CN120241601B (zh) * 2025-06-04 2025-08-22 成都苑东生物制药股份有限公司 盐酸麻黄碱注射液及其制剂工艺

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013532497A (ja) * 2010-07-17 2013-08-19 メルク パテント ゲーエムベーハー 浸透と作用の増強
JP2014510067A (ja) * 2011-03-04 2014-04-24 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
JP2017515603A (ja) * 2014-05-19 2017-06-15 メディコム・イノベーション・パートナー・アクティーゼルスカブＭｅｄｉｃｏｍ Ｉｎｎｏｖａｔｉｏｎ Ｐａｒｔｎｅｒ Ａ／Ｓ 一方弁を備えた医療用カートリッジ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
FR2890316B1 (fr) 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
FR2896168B1 (fr) 2006-01-19 2008-10-17 Aguettant Soc Par Actions Simp Seringue hypodermique preremplie equipee d'un dispositif de bouchage
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
FR2992222B1 (fr) 2012-06-22 2015-06-19 Aguettant Lab Dispositif de protection destine a equiper un dispositif d’injection pourvu d’un embout de raccordement
ES2770731T3 (es) * 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
FR3053893B1 (fr) 2016-07-13 2018-07-27 Laboratoire Aguettant Dispositif medical comportant un emballage et une seringue pre-remplie disposee dans l’emballage
CA3051467C (en) * 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
WO2019177725A1 (en) 2018-03-13 2019-09-19 Nevakar Inc. Prefilled syringe, compositions and methods
FR3084263B1 (fr) 2018-07-27 2020-07-10 Laboratoire Aguettant Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013532497A (ja) * 2010-07-17 2013-08-19 メルク パテント ゲーエムベーハー 浸透と作用の増強
JP2014510067A (ja) * 2011-03-04 2014-04-24 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
JP2017515603A (ja) * 2014-05-19 2017-06-15 メディコム・イノベーション・パートナー・アクティーゼルスカブＭｅｄｉｃｏｍ Ｉｎｎｏｖａｔｉｏｎ Ｐａｒｔｎｅｒ Ａ／Ｓ 一方弁を備えた医療用カートリッジ

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RECALL ONGOING FOR HYPOTENSION TREATMENT, JPN6023029360, 14 August 2017 (2017-08-14), ISSN: 0005423811 *
SCA PHARMACEUTICALS 2017-2018 PRODUCT CATALOG, JPN6023029361, 2018, pages 1 - 22, ISSN: 0005423810 *
STORMS, M.L., ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICAL COMPOUNDING, vol. 5, no. 5, JPN6023029362, 2001, pages 394 - 396, ISSN: 0005423812 *

Also Published As

Publication number Publication date
KR20240096847A (ko) 2024-06-26
US11464752B2 (en) 2022-10-11
US20210353561A1 (en) 2021-11-18
US20210393552A1 (en) 2021-12-23
US11090278B2 (en) 2021-08-17
AU2020276619A1 (en) 2021-12-16
US11241400B2 (en) 2022-02-08
US11478436B2 (en) 2022-10-25
CN113825500A (zh) 2021-12-21
JP2025071269A (ja) 2025-05-02
WO2020232424A1 (en) 2020-11-19
US20200360309A1 (en) 2020-11-19
US20220265580A2 (en) 2022-08-25
US20230068187A1 (en) 2023-03-02
EP3968975A4 (en) 2023-02-15
KR20220009985A (ko) 2022-01-25
EP3968975A1 (en) 2022-03-23
JP2023091072A (ja) 2023-06-29
US20220257539A1 (en) 2022-08-18
US11426369B2 (en) 2022-08-30
MX2021013888A (es) 2022-01-24
KR102675027B1 (ko) 2024-06-14
US20230025407A1 (en) 2023-01-26
CA3140043A1 (en) 2020-11-19
US20220110892A1 (en) 2022-04-14
US11571398B1 (en) 2023-02-07
IL288044A (en) 2022-01-01

Similar Documents

Publication Publication Date Title
US11571398B1 (en) Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
KR101632103B1 (ko) 덱스메데토미딘 프레믹스 제형
AU2020314494B2 (en) Stable AST-3424 injection preparation and preparation method
US11389538B2 (en) Method for removing acetaldehyde
US11413277B2 (en) Non-aqueous liquid nimodipine compositions
US12377081B2 (en) Liquid nimodipine compositions
US20070117851A1 (en) Liquid pharmaceutical compositions of nimodipine
HK40068558A (en) Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
US20240156724A1 (en) Multi-Dose Container for Ophthalmic Compositions
JPH10287569A (ja) アシクロビル又はその塩の輸液型キット注射剤
TW202317096A (zh) 酮咯酸（ｋｅｔｏｒｏｌａｃ）液體組合物、其製備方法及應用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230515

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230515

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230718

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231017

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240805

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240823

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20241004